|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,964.35 INR | +2.33% |
|
-1.83% | +23.39% |
| 05-15 | Hester Biosciences Limited, Q4 2026 Earnings Call, May 15, 2026 | |
| 05-15 | Hester Biosciences' Consolidated Profit Soars in Fiscal Q4; Shares Jump 10% | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 175M | ||
| 2.73% | 2.91% | 12.27x | 8.93x | 4.1x | 9.34x | 10.56x | 33.3B | ||
| -.--% | -.--% | 278x | 1.82x | 2.93x | 14.76x | 17.28x | 11.8B | ||
| 2.72% | 4.29% | 9.58x | 1.41x | 1.45x | 5.38x | 7.03x | 4.76B | ||
| 0.5% | 0.59% | 17.44x | 2.28x | 1.97x | 9.83x | 12.08x | 3.39B | ||
| 0.71% | 1.02% | 49.09x | 2.24x | - | - | - | 1.82B | ||
| -.--% | -.--% | 27.16x | 1.81x | 3.3x | 11.8x | 17.2x | 1.58B | ||
| 1.47% | 1.47% | 13.1x | 3.48x | 1.24x | 7.39x | 8.76x | 1.32B | ||
| 1.9% | 3.04% | 16.23x | 1.47x | 2.06x | 9.88x | 15.19x | 1.06B | ||
| 0.46% | 0.46% | 32.9x | 1.15x | - | - | - | 992M | ||
| 1.33% | 1.53% | 14.68x | 1.22x | 1.03x | 4.88x | 6.91x | 933M | ||
| 1.13% | 1.91% | 18.05x | 1.95x | - | - | - | 608M | ||
| 1.72% | 2.62% | 26.35x | 0.64x | 2.06x | 9.83x | 19.53x | 467M | ||
| Average | 1.22% | 1.65% | 42.90x | 2.37x | 2.24x | 9.23x | 12.73x | 4.78B | |
| Weighted average by Cap. | 1.84% | 2.1% | 64.99x | 5.64x | 3.33x | 10.10x | 11.95x |
- Stock Market
- Equities
- 524669 Stock
- Sector Hester Biosciences Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















